Page last updated: 2024-10-30

meclofenamic acid and Injury, Ischemia-Reperfusion

meclofenamic acid has been researched along with Injury, Ischemia-Reperfusion in 3 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saigo, C1
Nomura, Y1
Yamamoto, Y1
Sagata, M1
Matsunaga, R1
Jono, H1
Nishi, K1
Saito, H1
Fernández, N2
Martínez, MA1
Climent, B2
García-Villalón, AL2
Monge, L2
Sanz, E2
Diéguez, G2
Sánchez, A1

Other Studies

3 other studies available for meclofenamic acid and Injury, Ischemia-Reperfusion

ArticleYear
Meclofenamate elicits a nephropreventing effect in a rat model of ischemic acute kidney injury by suppressing indoxyl sulfate production and restoring renal organic anion transporters.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Urea Nitrogen; Creatini

2014
In vivo coronary effects of endothelin-1 after ischemia-reperfusion. Role of nitric oxide and prostanoids.
    European journal of pharmacology, 2003, Nov-14, Volume: 481, Issue:1

    Topics: Acetylcholine; Animals; Coronary Vessels; Cyclooxygenase Inhibitors; Dose-Response Relationship, Dru

2003
Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids.
    European journal of pharmacology, 2005, Nov-07, Volume: 524, Issue:1-3

    Topics: Animals; Arteries; Blood Pressure; Coronary Vessels; Cyclooxygenase Inhibitors; Dose-Response Relati

2005